Cost-benefit analysis of the work-up for pancreatic cancer. Discussion.
Society for surgery of the alimentary tract. Annual meeting. San Francisco CA (USA), 1992/05/11.
We reviewed the records of 126 patients with pancreatic cancer to assess the value of diagnostic tests.
The most commonly performed studies were computed tomography (CT) (97% of patients), endoscopic retrograde cholangiopancreatography (ERCP) (44%), and fine-needle aspiration (FNA), (41%). Of 34 patients who were found to have a mass in the body or tail of the pancreas on CT, 13 underwent ERCP; the results found by ERCP did not affect the management of the patients, whereas the results of FNA in 12 patients eliminated the need for operation.
Mots-clés Pascal : Tumeur maligne, Pancréas, Homme, Diagnostic, Exploration, Méthodologie, Etude comparative, Analyse avantage coût, Aspect économique, Economie santé, Pancréas pathologie, Appareil digestif pathologie
Mots-clés Pascal anglais : Malignant tumor, Pancreas, Human, Diagnosis, Exploration, Methodology, Comparative study, Cost benefit analysis, Economic aspect, Health economy, Pancreatic disease, Digestive diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0345135
Code Inist : 002B13C01. Création : 199406.